Cormorant Asset Management, LP → Biomea Fusion, Inc. BMEA

Stake: 5.31% Shares: 3,681,664 CUSIP: 09077A106 Class: Common Stock

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-08-31

DTC 4.96

11,949,049 shares short · +21.7% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $21K

Point72 Asset Mgmt

Post-Filing Returns · since 2025-10-08 on BMEA

+1 day

+6.5%

+5 days

-1.8%

+30 days

-18.5%

+60 days

-19.6%

+90 days

-25.0%

+180 days

-10.1%

Anchor price 1.68 on closest trading day on/after 2025-10-08. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on Biomea Fusion, Inc.

Filed	Form	Filer	Stake	Shares
2023-04-03	SC	Cormorant Global Healthcare Master Fund, LP	—	—	view →

Other Filings by Cormorant Asset Management, LP

Filed	Form	Issuer	Stake	Shares
2026-08-13	SCHEDULE 13D	BlossomHill Therapeutics, Inc.	11.80%	959,090	view →
2021-08-10	SC	Erasca, Inc. ERAS	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →